LadRx (LADX, $1.8) was a top loser over the last three months, falling -3 to $1.8 per share. A.I.dvisor analyzed 857 stocks in the Biotechnology Industry for the 3-month period ending September 27, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.